Natixis Investment Managers International’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,767
Closed -$999K 418
2022
Q2
$999K Buy
+4,767
New +$1.01M 0.02% 223
2018
Q4
Sell
-9,724
Closed -$1.12M 457
2018
Q3
$1.12M Buy
9,724
+2,939
+43% +$322K 0.05% 316
2018
Q2
$703K Buy
+6,785
New +$687K 0.04% 348
2017
Q3
Sell
-1,400
Closed -$109K 428
2017
Q2
$109K Hold
1,400
0.01% 351
2017
Q1
$101K Hold
1,400
0.01% 362
2016
Q4
$87K Buy
+1,400
New +$85.7K 0.01% 395
2015
Q2
Sell
-4,789
Closed -$344K 459
2015
Q1
$344K Buy
4,789
+4,090
+585% +$266K 0.04% 239
2014
Q4
$39K Buy
+699
New +$36.5K 0.01% 392

Other funds holding RMD

Natixis Investment Managers International's RMD Position: Q3 2022 in Review

Natixis Investment Managers International sold out of ResMed (RMD) in Q3 2022, closing a stake of 4,767 shares — an estimated $999K sold.

Natixis Investment Managers International first reported a position in RMD in Q4 2014 and held it in 8 quarters. The position peaked at $1.12M in Q3 2018. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.

  • Natixis Investment Managers International reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 4,767 ResMed shares in Q3 2022, an estimated $999K.
  • Natixis Investment Managers International first reported a position in ResMed in Q4 2014 and held it in 8 quarters.
  • Natixis Investment Managers International's ResMed position peaked at $1.12M in Q3 2018.
  • 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.